HOMOMERIC AND HETEROMERIC RECEPTOR COMPLEX FORMATION OF BONE MORPHOGENETIC TYPE I RECEPTORS ALK2 AND ALK3

被引：0
|
作者：
Traeger, Lisa [1 ]
Gallitz, Inka [1 ]
Sekhri, Rohit [1 ]
Baeumer, Nicole [2 ]
Kuhlmann, Tanja [3 ]
Kemming, Claudia [3 ]
Bartnikas, Thomas B. [4 ]
Steinbicker, Andrea U. [1 ]
机构：
[1] Univ Hosp Muenster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany
[2] Univ Hosp Muenster, Dept Med Hematol & Oncol A, Munster, Germany
[3] Univ Hosp Muenster, Inst Neuropathol, Munster, Germany
[4] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2017年 / 92卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
207
引用
收藏
页码：E448 / E448
页数：1
相关论文
共 50 条
  • [41] Formation of Stable Homomeric and Transient Heteromeric Bone Morphogenetic Protein (BMP) Receptor Complexes Regulates Smad Protein Signaling
    Marom, Barak
    Heining, Eva
    Knaus, Petra
    Henis, Yoav I.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (22) : 19287 - 19296
  • [42] The recombinant expression of bone morphogenetic protein type IA receptor (Alk3) in mesenchymal progenitors C3H10T1/2 Is sufficient for osteo-/chondrogenic development
    Kaps, C
    Lauber, J
    Ju, W
    Czichos, S
    Gross, G
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1998, 26 (01) : 27 - 32
  • [43] The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes
    Colucci, Silvia
    Pagani, Alessia
    Pettinato, Mariateresa
    Artuso, Irene
    Nai, Antonella
    Camaschella, Clara
    Silvestri, Laura
    BLOOD, 2017, 130 (19) : 2111 - 2120
  • [44] Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2
    Macías-Silva, M
    Hoodless, PA
    Tang, SJ
    Buchwald, M
    Wrana, JL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) : 25628 - 25636
  • [45] Cardiac-specific deletion of ALK3, the type IA receptor for bone morphogenetic proteins, unmasks an essential, myocyte-autonomous role in the mid-gestation heart
    Gaussin, V
    Van de Putte, T
    Mishina, Y
    Zwijsen, A
    Huylebroeck, D
    Behringer, RR
    Schneider, MD
    CIRCULATION, 2000, 102 (18) : 15 - 15
  • [46] Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin
    Olsen, O. E.
    Wader, K. F.
    Misund, K.
    Vatsveen, T. K.
    Ro, T. B.
    Mylin, A. K.
    Turesson, I.
    Stordal, B. F.
    Moen, S. H.
    Standal, T.
    Waage, A.
    Sundan, A.
    Holien, T.
    BLOOD CANCER JOURNAL, 2014, 4 : e196 - e196
  • [47] Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin
    O E Olsen
    K F Wader
    K Misund
    T K Våtsveen
    T B Rø
    A K Mylin
    I Turesson
    B F Størdal
    S H Moen
    T Standal
    A Waage
    A Sundan
    T Holien
    Blood Cancer Journal, 2014, 4 : e196 - e196
  • [48] IDENTIFICATION OF A HUMAN TYPE-II RECEPTOR FOR BONE MORPHOGENETIC PROTEIN-4 THAT FORMS DIFFERENTIAL HETEROMERIC COMPLEXES WITH BONE MORPHOGENETIC PROTEIN TYPE-I RECEPTORS
    NOHNO, T
    ISHIKAWA, T
    SAITO, T
    HOSOKAWA, K
    NOJI, S
    WOLSING, DH
    ROSENBAUM, JS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (38) : 22522 - 22526
  • [49] Targeting of ALK2, a Receptor for Bone Morphogenetic Proteins, Using the Cre/lox System to Enhance Osseous Regeneration by Adipose-Derived Stem Cells
    Peterson, Jonathan R.
    Eboda, Oluwatobi
    Agarwal, Shailesh
    Ranganathan, Kavitha
    Buchman, Steven R.
    Lee, Min
    Wang, Stewart C.
    Mishina, Yuji
    Levi, Benjamin
    STEM CELLS TRANSLATIONAL MEDICINE, 2014, 3 (11) : 1375 - 1380
  • [50] The type IBMP receptors ALK3 & ALK6 function similarly in controlling osteoblast and adipocyte differentiation from human mesenchymal stem cells.
    Emery, JG
    Mathur, AS
    Rieman, DJ
    Kaing, MT
    Geubtner, KA
    Bender, CN
    Gowen, M
    Lark, M
    Suva, LJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S186 - S186
12345